CIVETTA THERAPEUTICS

civetta-therapeutics-logo

Civetta Therapeutics is a cancer therapeutics company to advance new medicines through small molecule targeting of beta-propeller domains. The company leverages small molecule targeting of beta-propeller domains to develop important therapeutics for cancers and other diseases. It also develops a broad range of expertise in drugging the propeller domains, spanning from biochemistry to biology to medicinal chemistry Propeller proteins are structural scaffolds that mediate protein-protein interact... ions of unique substrates. These proteins are found ubiquitously across cell types and can have diverse functional roles in the pathogenesis of cancer, neurodegeneration, metabolic disease, and other areas. Their vision is to build a portfolio of therapeutics by integrating a broad range of expertise in drugging the propeller domains spanning from biochemistry to biology to medicinal chemistry. These efforts will support the creation of near term therapeutics and longer-term value in becoming a leader in this space. Civetta Therapeutics was founded in 2019 and is based in Cambridge, Massachusetts, United States.

#SimilarOrganizations #People #Financial #Event #Website #More

CIVETTA THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2019-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.civettatherapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
53 M USD

Technology used in webpage:
Viewport Meta Google Font API Content Delivery Network Euro Organization Schema AJAX Libraries API Typekit LocalBusiness Schema Squarespace


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

cerevance-logo

Cerevance

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

cybrexa-therapeutics-logo

Cybrexa Therapeutics

Cybrexa Therapeutics is a cancer therapeutics company developing a new class of small molecule DNA repair.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Current Employees Featured

earl-may_image

Earl May
Earl May Vice President of Lead Discovery @ Civetta Therapeutics
Vice President of Lead Discovery
2019-04-01

joseph-kelleher_image

Joseph Kelleher
Joseph Kelleher Vice President of Biology @ Civetta Therapeutics
Vice President of Biology
2019-07-01

william-sellers_image

William Sellers
William Sellers Co-Founder @ Civetta Therapeutics
Co-Founder

eric-fischer_image

Eric Fischer
Eric Fischer Co-Founder @ Civetta Therapeutics
Co-Founder

andrew-cook_image

Andrew Cook
Andrew Cook Vice President and Head of Chemistry @ Civetta Therapeutics
Vice President and Head of Chemistry
2019-09-01

susan-ashwell_image

Susan Ashwell
Susan Ashwell Senior Vice President,Chemistry @ Civetta Therapeutics
Senior Vice President,Chemistry
2022-03-01

jesse-smith_image

Jesse Smith
Jesse Smith Chief Scientific Officer @ Civetta Therapeutics
Chief Scientific Officer
2022-03-01

kevin-mills_image

Kevin Mills
Kevin Mills SVP @ Civetta Therapeutics
SVP
2021-01-01

not_available_image

Christopher D. Roberts
Christopher D. Roberts CEO @ Civetta Therapeutics
CEO
2021-01-01

not_available_image

Catharine Johnson
Catharine Johnson Chief Business Officer @ Civetta Therapeutics
Chief Business Officer
2020-12-01

Founder


eric-fischer_image

Eric Fischer

william-sellers_image

William Sellers

Investors List

deerfield_image

Deerfield

Deerfield investment in Series A - Civetta Therapeutics

Official Site Inspections

http://www.civettatherapeutics.com

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Civetta Therapeutics"

Civetta Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Civetta Therapeutics is a cancer therapeutics company to advance new medicines through small molecule …See details»

Civetta Company Profile 2024: Valuation, Funding & Investors

Civetta General Information Description. Developer of molecule targeting medication intended to develop a cure for cancer and other diseases. The company's medication specializes in …See details»

Civetta Therapeutics - VentureRadar

"Civetta is a Cambridge, MA based cancer therapeutics company, founded to advance new medicines through small molecule targeting of beta-propeller domains with the goal of …See details»

Civetta Therapeutics - Overview, News & Similar companies

May 17, 2022 Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry CAMBRIDGE, Mass.--(BUSINESS WIRE)--Civetta Therapeutics, …See details»

Civetta Therapeutics, LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Civetta Therapeutics, LLC of Chicago, IL. Get the latest business insights from Dun & Bradstreet.See details»

Civetta Therapeutics Company Profile | Management and

Company Name. Civetta Therapeutics. Main Industry. Research & Development, Business Services. Website. www.civettatherapeutics.comSee details»

Civetta Therapeutics - LinkedIn

Civetta Therapeutics Biotechnology Research Cambridge, Massachusetts 2,369 followers Civetta is pioneering the development of therapies that target beta-propeller domains to treat cancer …See details»

Civetta Therapeutics LLC: Drug pipelines, Patents, Clinical trials ...

Jul 3, 2023 Explore Civetta Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 1 news.See details»

Civetta Therapeutics - Company Profile - Tracxn

Oct 22, 2024 Civetta Therapeutics ranks 668th among 2371 active competitors. 857 of its competitors are funded while 543 have exited. Overall, Civetta Therapeutics and its …See details»

Civetta Therapeutics Company Profile -Sales, Contacts, …

Civetta Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»

Civetta Therapeutics Management Team | Org Chart

Civetta Therapeutics employs 25 employees. The Civetta Therapeutics management team includes Christopher Roberts (Chief Executive Officer (thru Aug2023)), Catharine Johnson …See details»

Civetta Therapeutics - Products, Competitors, Financials, …

Civettatherapeutics.com. Overview & Products; Financials; People; Founded Year 2019. Stage Series A | Alive. Total Raised $53M. Last Raised $53M | 5 yrs ago. Mosaic Score. The Mosaic …See details»

Civetta Therapeutics - Craft

Civetta Therapeutics has 5 employees across 2 locations and $53 m in total funding,. See insights on Civetta Therapeutics including office locations, competitors, revenue, financials, executives, …See details»

Civetta Therapeutics | VentureRadar

6 days ago Website: https://www.civettatherapeutics.com/ Develops innovative therapies targeting beta-propeller domains using small molecules, aiming to treat various diseases ...See details»

Nextsource | Company Profile | Civetta Therapeutics

Explore the company profile of Civetta Therapeutics (civettatherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

Coulter Partners secures Chief Executive Officer for Civetta

Cambridge, MA – 21 September 2021 – Coulter Partners, a global Life Sciences, Health and Technology executive search specialist, was delighted to partner with Civetta Therapeutics, …See details»

Civetta Therapeutics - VentureRadar

Similar Companies: Cybrexa Therapeutics USA Privately Held Cybrexa is a privately funded biotechnology company dedicated to developing an entirely new class of small molecule DNA …See details»

Civetta Therapeutics Announces $53 million Series A to Advance …

Civetta is a Cambridge, MA based cancer therapeutics company, founded to advance new medicines through small molecule targeting of beta-propeller domains with the goal of …See details»

Civetta launches with $53 million to target propeller proteins

Dec 12, 2019 The health-care investment firm Deerfield Management has launched a biotech start-up called Civetta Therapeutics with $53 million in series A financing.See details»

Civetta Therapeutics Announces $53 million Series A to Advance …

Dec 4, 2019 Civetta Therapeutics Bruce Goldsmith 857-999-3806 [email protected]. Site Navigation. Home. Home; Submit a Press Release; …See details»

linkstock.net © 2022. All rights reserved